How Aspirin Harms Blood Disorders
Aspirin inhibits platelet aggregation and prolongs bleeding time by blocking cyclooxygenase-1 (COX-1), which reduces thromboxane A2 production. This effect heightens bleeding risk in disorders with impaired clotting or low platelets.[1]
Hemophilia and Other Coagulation Factor Deficiencies
In hemophilia A (factor VIII deficiency) or B (factor IX deficiency), aspirin's antiplatelet action worsens spontaneous or trauma-induced bleeding into joints, muscles, or the gut. Even low doses can trigger prolonged hemorrhages.[1][2]
Thrombocytopenia and Platelet Disorders
Conditions like immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), or drug-induced low platelet counts (<50,000/μL) amplify aspirin's bleeding risk. It impairs the few available platelets, leading to purpura, epistaxis, or gastrointestinal bleeds.[1][3]
Von Willebrand Disease
This common inherited disorder reduces von Willebrand factor, essential for platelet adhesion. Aspirin further disrupts platelet function, increasing mucosal bleeding like epistaxis or menorrhagia.[2]
Uremia in Chronic Kidney Disease
Uremic platelet dysfunction, from accumulated toxins, combines with aspirin's effects to cause severe bleeding, especially from uremic gastropathy or surgical sites.[1]
Acquired Bleeding Disorders
Liver disease (reducing clotting factors), vitamin K deficiency, or disseminated intravascular coagulation (DIC) heighten risks. Aspirin exacerbates mucosal and postoperative bleeding in these states.[3]
When Doctors Avoid Aspirin
Guidelines from the American College of Chest Physicians recommend avoiding aspirin in active bleeding or platelet counts below 50,000/μL. Alternatives like acetaminophen are preferred for pain relief.[1][2] Always consult a hematologist before use.
[1]: UpToDate: Aspirin and bleeding disorders
[2]: American Society of Hematology: Antiplatelet therapy in hemostatic disorders
[3]: NEJM: Platelet function and bleeding risks